Literature DB >> 21329743

Preproglucagon neurons project widely to autonomic control areas in the mouse brain.

I J Llewellyn-Smith1, F Reimann, F M Gribble, S Trapp.   

Abstract

Glucagon-like peptide 1 (GLP-1) and its analogue exendin-4 inhibit food intake, reduce blood glucose levels and increase blood pressure and heart rate by acting on GLP-1 receptors in many brain regions. Within the CNS, GLP-1 is produced only by preproglucagon (PPG) neurons. We suggest that PPG neurons mediate the central effects of GLP-1 by modulating sympathetic and vagal outflow. We therefore analysed the projections of PPG neurons to brain sites involved in autonomic control. In transgenic mice expressing yellow fluorescent protein (YFP) under the control of the PPG promoter, we assessed YFP-immunoreactive innervation using an anti-GFP antiserum and avidin-biotin-peroxidase. PPG neurons were intensely YFP-immunoreactive and axons could be easily discriminated from dendrites. YFP-immunoreactive cell bodies occurred primarily within the caudal nucleus tractus solitarius (NTS) with additional somata ventral to the hypoglossal nucleus, in raphé obscurus and in the intermediate reticular nucleus. The caudal NTS contained a dense network of dendrites, some of which extended into the area postrema. Immunoreactive axons were widespread throughout NTS, dorsal vagal nucleus and reticular nucleus with few in the hypoglossal nucleus and pyramids. The dorsomedial and paraventricular hypothalamic nuclei, ventrolateral periaqueductal grey and thalamic paraventricular nucleus exhibited heavy innervation. The area postrema, rostral ventrolateral medulla, pontine central grey, locus coeruleus/Barrington's nucleus, arcuate nucleus and the vascular organ of the lamina terminalis were moderately innervated. Only a few axons occurred in the amygdala and subfornical organ. Our results demonstrate that PPG neurons innervate primarily brain regions involved in autonomic control. Thus, central PPG neurons are ideally situated to modulate sympathetic and parasympathetic outflow through input at a variety of central sites. Our data also highlight that immunohistochemistry improves detection of neurons expressing YFP. Hence, animals in which specific populations of neurons have been genetically-modified to express fluorescent proteins are likely to prove ideal for anatomical studies.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329743      PMCID: PMC4298012          DOI: 10.1016/j.neuroscience.2011.02.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  35 in total

1.  Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.

Authors:  J J Holst; C F Deacon
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

2.  Enkephalin-immunoreactive interneurons extensively innervate sympathetic preganglionic neurons regulating the pelvic viscera.

Authors:  Ida J Llewellyn-Smith; Stephen E Dicarlo; Heidi L Collins; Janet R Keast
Journal:  J Comp Neurol       Date:  2005-08-01       Impact factor: 3.215

3.  Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Authors:  A Flint; A Raben; A Astrup; J J Holst
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

4.  Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons.

Authors:  S Wan; F H Coleman; R A Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-02-22       Impact factor: 4.052

5.  Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

Authors:  Abba J Kastin; Victoria Akerstrom; Weihong Pan
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

6.  Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

Authors:  Diana L Williams; Denis G Baskin; Michael W Schwartz
Journal:  Endocrinology       Date:  2008-12-12       Impact factor: 4.736

Review 7.  The physiology of glucagon-like peptide 1.

Authors:  Jens Juul Holst
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

8.  Synaptic relations of GABAergic neurons in the area postrema.

Authors:  J L Guan; Q P Wang; H Ochiai; Y Nakai
Journal:  Acta Anat (Basel)       Date:  1994

9.  Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei.

Authors:  Miyuki Tauchi; Rong Zhang; David A D'Alessio; Javier E Stern; James P Herman
Journal:  J Chem Neuroanat       Date:  2008-08-19       Impact factor: 3.052

10.  Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study.

Authors:  S L Jin; V K Han; J G Simmons; A C Towle; J M Lauder; P K Lund
Journal:  J Comp Neurol       Date:  1988-05-22       Impact factor: 3.215

View more
  99 in total

Review 1.  Developmental specification of metabolic circuitry.

Authors:  Amanda E Elson; Richard B Simerly
Journal:  Front Neuroendocrinol       Date:  2015-09-25       Impact factor: 8.606

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 3.  Brain GLP-1 and insulin sensitivity.

Authors:  Darleen Sandoval; Stephanie R Sisley
Journal:  Mol Cell Endocrinol       Date:  2015-02-24       Impact factor: 4.102

4.  Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior.

Authors:  Anne E Harasta; John M Power; Georg von Jonquieres; Tim Karl; Daniel J Drucker; Gary D Housley; Miriam Schneider; Matthias Klugmann
Journal:  Neuropsychopharmacology       Date:  2015-02-11       Impact factor: 7.853

5.  Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling.

Authors:  Yu-Hong Cheng; Mei-Shang Ho; Wei-Ting Huang; Ying-Ting Chou; Klim King
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

Review 6.  Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms.

Authors:  Sean Manning; Andrea Pucci; Rachel L Batterham
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

7.  Activation of murine pre-proglucagon-producing neurons reduces food intake and body weight.

Authors:  Ronald P Gaykema; Brandon A Newmyer; Matteo Ottolini; Vidisha Raje; Daniel M Warthen; Philip S Lambeth; Maria Niccum; Ting Yao; Yiru Huang; Ira G Schulman; Thurl E Harris; Manoj K Patel; Kevin W Williams; Michael M Scott
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

Review 8.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

9.  Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food.

Authors:  Marie K Holt; James E Richards; Daniel R Cook; Daniel I Brierley; Diana L Williams; Frank Reimann; Fiona M Gribble; Stefan Trapp
Journal:  Diabetes       Date:  2018-10-02       Impact factor: 9.461

Review 10.  The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.

Authors:  Xinfu Guan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.